img

Global and United States Antiviral Drug Packaging Market Report & Forecast 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Packaging

Publisher : MRA | Format : PDF

Global and United States Antiviral Drug Packaging Market Report & Forecast 2024-2034

Antiviral drug packaging is specially designed for packaging antiviral drugs. Antiviral drugs are a class of medication used specifically for treating viral infections such as influenza, herpes virus infections, viral hepatitis and human immunodeficiency virus.
Market Analysis and InsightsGlobal and United States Antiviral Drug Packaging Market
This report focuses on global and United States Antiviral Drug Packaging market, also covers the segmentation data of other regions in regional level and county level.
The global Antiviral Drug Packaging revenue was US$ 26500 million in 2022 and is forecast to a readjusted size of US$ 34130 million by 2029 with a CAGR of 3.7% during the forecast period (2023-2029).
In United States the Antiviral Drug Packaging revenue is expected to grow from US$ million in 2022 to US$ million by 2029, at a CAGR of % during the forecast period (2023-2029).
The global key players of Antiviral Drug Packaging include Avery Dennison Corporation, E.I. du Pont de Nemours, CCL Industries Inc, BioCote, Avient, Mondi, Biomaster, BASF and Lonza, etc. The global five biggest players hold a share of % in 2022.
Global Antiviral Drug Packaging Scope and Market Size
Antiviral Drug Packaging market is segmented in regional and country, by players, by material and by application. Companies, stakeholders, and other participants in the global Antiviral Drug Packaging market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by material and by application for the period 2018-2029.
For United States market, this report focuses on the Antiviral Drug Packaging market size by players, by Material and by Application, for the period 2018-2029. The key players include the global and local players, which play important roles in United States.



By Company


Avery Dennison Corporation
E.I. du Pont de Nemours
CCL Industries Inc
BioCote
Avient
Mondi
Biomaster
BASF
Lonza
Takex Labo Co. Ltd
Berry
Lageen Tubes.
Segment by Material
Rigid Plastic
Flexible Blister Foils
Others

Segment by Application


Pharmaceuticals
Healthcare
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa

Chapter Introduction


Chapter 1Introduces Antiviral Drug Packaging definition, global sales (volume and revenue), United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by material, covering the volume, price, revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue, price, volume, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Antiviral Drug Packaging companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Revenue and volume of Antiviral Drug Packaging in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 6Americas by material, by application and by country, sales, and revenue for each segment.
Chapter 7EMEA by material, by application and by region, sales, and revenue for each segment.
Chapter 8China by material, by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by material, by application and by region, sales, and revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Antiviral Drug Packaging sales, revenue, gross margin, and recent development, etc.
Chapter 11Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 12Research findings and conclusion

Table of Content

1 Study Coverage
1.1 Antiviral Drug Packaging Product Introduction
1.2 Global Antiviral Drug Packaging Outlook 2018 VS 2022 VS 2029
1.2.1 Global Antiviral Drug Packaging Sales in US$ Million for the Year 2018-2029
1.2.2 Global Antiviral Drug Packaging Sales in Volume for the Year 2018-2029
1.3 United States Antiviral Drug Packaging Outlook 2018 VS 2022 VS 2029
1.3.1 United States Antiviral Drug Packaging Sales in US$ Million for the Year 2018-2029
1.3.2 United States Antiviral Drug Packaging Sales in Volume for the Year 2018-2029
1.4 Antiviral Drug Packaging Market Size, United States VS Global, 2018 VS 2022 VS 2029
1.4.1 The Market Share of United States Antiviral Drug Packaging in Global, 2018 VS 2022 VS 2029
1.4.2 The Growth Rate of Antiviral Drug Packaging Market Size, United States VS Global, 2018 VS 2022 VS 2029
1.5 Antiviral Drug Packaging Market Dynamics
1.5.1 Antiviral Drug Packaging Industry Trends
1.5.2 Antiviral Drug Packaging Market Drivers
1.5.3 Antiviral Drug Packaging Market Challenges
1.5.4 Antiviral Drug Packaging Market Restraints
1.6 Study Objectives
1.7 Years Considered
1.8 Years Considered
2 Antiviral Drug Packaging by Material
2.1 Antiviral Drug Packaging Market Segment by Material
2.1.1 Rigid Plastic
2.1.2 Flexible Blister Foils
2.1.3 Others
2.2 Global Antiviral Drug Packaging Market Size by Material
2.2.1 Global Antiviral Drug Packaging Sales in Value, by Material (2018, 2022 & 2029)
2.2.2 Global Antiviral Drug Packaging Sales in Volume, by Material (2018, 2022 & 2029)
2.2.3 Global Antiviral Drug Packaging Average Selling Price (ASP) by Material (2018, 2022 & 2029)
2.3 United States Antiviral Drug Packaging Market Size by Material
2.3.1 United States Antiviral Drug Packaging Sales in Value, by Material (2018, 2022 & 2029)
2.3.2 United States Antiviral Drug Packaging Sales in Volume, by Material (2018, 2022 & 2029)
2.3.3 United States Antiviral Drug Packaging Average Selling Price (ASP) by Material (2018, 2022 & 2029)
3 Antiviral Drug Packaging by Application
3.1 Antiviral Drug Packaging Market Segment by Application
3.1.1 Pharmaceuticals
3.1.2 Healthcare
3.2 Global Antiviral Drug Packaging Market Size by Application
3.2.1 Global Antiviral Drug Packaging Sales in Value, by Application (2018, 2022 & 2029)
3.2.2 Global Antiviral Drug Packaging Sales in Volume, by Application (2018, 2022 & 2029)
3.3.3 Global Antiviral Drug Packaging Average Selling Price (ASP) by Application (2018, 2022 & 2029)
3.3 United States Antiviral Drug Packaging Market Size by Application
3.3.1 United States Antiviral Drug Packaging Sales in Value, by Application (2018, 2022 & 2029)
3.3.2 United States Antiviral Drug Packaging Sales in Volume, by Application (2018, 2022 & 2029)
3.3.3 United States Antiviral Drug Packaging Average Selling Price (ASP) by Application (2018, 2022 & 2029)
4 Global Antiviral Drug Packaging Competitor Landscape by Company
4.1 Global Antiviral Drug Packaging Market Size by Company
4.1.1 Global Key Manufacturers of Antiviral Drug Packaging, Ranked by Revenue (2022)
4.1.2 Global Antiviral Drug Packaging Revenue by Manufacturer (2018-2023)
4.1.3 Global Antiviral Drug Packaging Sales by Manufacturer (2018-2023)
4.1.4 Global Antiviral Drug Packaging Price by Manufacturer (2018-2023)
4.2 Global Antiviral Drug Packaging Concentration Ratio (CR)
4.2.1 Antiviral Drug Packaging Market Concentration Ratio (CR)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Antiviral Drug Packaging in 2022
4.2.3 Global Antiviral Drug Packaging Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Manufacturers of Antiviral Drug Packaging, Manufacturing Base Distribution and Headquarters
4.4 Global Key Manufacturers of Antiviral Drug Packaging, Product Offered and Application
4.5 Global Key Manufacturers of Antiviral Drug Packaging, Date of Enter into This Industry
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4.7 United States Antiviral Drug Packaging Market Size by Company
4.7.1 Key Players of Antiviral Drug Packaging in United States, Ranked by Revenue (2022)
4.7.2 United States Antiviral Drug Packaging Revenue by Players (2018-2023)
4.7.3 United States Antiviral Drug Packaging Sales by Players (2018-2023)
5 Global Antiviral Drug Packaging Market Size by Region
5.1 Global Antiviral Drug Packaging Market Size by Region: 2018 VS 2022 VS 2029
5.2 Global Antiviral Drug Packaging Market Size in Volume by Region (2018-2029)
5.2.1 Global Antiviral Drug Packaging Sales in Volume by Region: 2018-2023
5.2.2 Global Antiviral Drug Packaging Sales in Volume Forecast by Region (2024-2029)
5.3 Global Antiviral Drug Packaging Market Size in Value by Region (2018-2029)
5.3.1 Global Antiviral Drug Packaging Sales in Value by Region: 2018-2023
5.3.2 Global Antiviral Drug Packaging Sales in Value by Region: 2024-2029
6 Americas
6.1 Americas Antiviral Drug Packaging Market Size YoY Growth 2018-2029
6.2 Americas Antiviral Drug Packaging Sales in Volume, by Material (2018, 2022 & 2029)
6.3 Americas Antiviral Drug Packaging Sales in Volume, by Application (2018, 2022 & 2029)
6.4 Americas Antiviral Drug Packaging Market Facts & Figures by Country (2018, 2022 & 2029)
6.4.1 Americas Antiviral Drug Packaging Sales in Value by Country (2018, 2022 & 2029)
6.4.2 Americas Antiviral Drug Packaging Sales in Volume by Country (2018, 2022 & 2029)
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
6.4.6 Brazil
7 EMEA
7.1 EMEA Antiviral Drug Packaging Market Size YoY Growth 2018-2029
7.2 EMEA Antiviral Drug Packaging Sales in Volume, by Material (2018, 2022 & 2029)
7.3 EMEA Antiviral Drug Packaging Sales in Volume, by Application (2018, 2022 & 2029)
7.4 EMEA Antiviral Drug Packaging Market Facts & Figures by Country (2018, 2022 & 2029)
7.4.1 EMEA Antiviral Drug Packaging Sales in Value by Country (2018, 2022 & 2029)
7.4.2 EMEA Antiviral Drug Packaging Sales in Volume by Country (2018, 2022 & 2029)
7.4.3 Europe
7.4.4 Middle East
7.4.5 Africa
8 China
8.1 China Antiviral Drug Packaging Market Size YoY Growth 2018-2029
8.2 China Antiviral Drug Packaging Sales in Volume, by Material (2018, 2022 & 2029)
8.3 China Antiviral Drug Packaging Sales in Volume, by Application (2018, 2022 & 2029)
9 APAC
9.1 APAC Antiviral Drug Packaging Market Size YoY Growth 2018-2029
9.2 APAC Antiviral Drug Packaging Sales in Volume, by Material (2018, 2022 & 2029)
9.3 APAC Antiviral Drug Packaging Sales in Volume, by Application (2018, 2022 & 2029)
9.4 APAC Antiviral Drug Packaging Market Facts & Figures by Region (2018, 2022 & 2029)
9.4.1 APAC Antiviral Drug Packaging Sales in Value by Region (2018, 2022 & 2029)
9.4.2 APAC Antiviral Drug Packaging Sales in Volume by Region (2018, 2022 & 2029)
9.4.3 Japan
9.4.4 South Korea
9.4.5 China Taiwan
9.4.6 Southeast Asia
9.4.7 India
10 Company Profiles
10.1 Avery Dennison Corporation
10.1.1 Avery Dennison Corporation Company Information
10.1.2 Avery Dennison Corporation Description and Business Overview
10.1.3 Avery Dennison Corporation Antiviral Drug Packaging Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Avery Dennison Corporation Antiviral Drug Packaging Products Offered
10.1.5 Avery Dennison Corporation Recent Development
10.2 E.I. du Pont de Nemours
10.2.1 E.I. du Pont de Nemours Company Information
10.2.2 E.I. du Pont de Nemours Description and Business Overview
10.2.3 E.I. du Pont de Nemours Antiviral Drug Packaging Sales, Revenue and Gross Margin (2018-2023)
10.2.4 E.I. du Pont de Nemours Antiviral Drug Packaging Products Offered
10.2.5 E.I. du Pont de Nemours Recent Development
10.3 CCL Industries Inc
10.3.1 CCL Industries Inc Company Information
10.3.2 CCL Industries Inc Description and Business Overview
10.3.3 CCL Industries Inc Antiviral Drug Packaging Sales, Revenue and Gross Margin (2018-2023)
10.3.4 CCL Industries Inc Antiviral Drug Packaging Products Offered
10.3.5 CCL Industries Inc Recent Development
10.4 BioCote
10.4.1 BioCote Company Information
10.4.2 BioCote Description and Business Overview
10.4.3 BioCote Antiviral Drug Packaging Sales, Revenue and Gross Margin (2018-2023)
10.4.4 BioCote Antiviral Drug Packaging Products Offered
10.4.5 BioCote Recent Development
10.5 Avient
10.5.1 Avient Company Information
10.5.2 Avient Description and Business Overview
10.5.3 Avient Antiviral Drug Packaging Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Avient Antiviral Drug Packaging Products Offered
10.5.5 Avient Recent Development
10.6 Mondi
10.6.1 Mondi Company Information
10.6.2 Mondi Description and Business Overview
10.6.3 Mondi Antiviral Drug Packaging Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Mondi Antiviral Drug Packaging Products Offered
10.6.5 Mondi Recent Development
10.7 Biomaster
10.7.1 Biomaster Company Information
10.7.2 Biomaster Description and Business Overview
10.7.3 Biomaster Antiviral Drug Packaging Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Biomaster Antiviral Drug Packaging Products Offered
10.7.5 Biomaster Recent Development
10.8 BASF
10.8.1 BASF Company Information
10.8.2 BASF Description and Business Overview
10.8.3 BASF Antiviral Drug Packaging Sales, Revenue and Gross Margin (2018-2023)
10.8.4 BASF Antiviral Drug Packaging Products Offered
10.8.5 BASF Recent Development
10.9 Lonza
10.9.1 Lonza Company Information
10.9.2 Lonza Description and Business Overview
10.9.3 Lonza Antiviral Drug Packaging Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Lonza Antiviral Drug Packaging Products Offered
10.9.5 Lonza Recent Development
10.10 Takex Labo Co. Ltd
10.10.1 Takex Labo Co. Ltd Company Information
10.10.2 Takex Labo Co. Ltd Description and Business Overview
10.10.3 Takex Labo Co. Ltd Antiviral Drug Packaging Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Takex Labo Co. Ltd Antiviral Drug Packaging Products Offered
10.10.5 Takex Labo Co. Ltd Recent Development
10.11 Berry
10.11.1 Berry Company Information
10.11.2 Berry Description and Business Overview
10.11.3 Berry Antiviral Drug Packaging Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Berry Antiviral Drug Packaging Products Offered
10.11.5 Berry Recent Development
10.12 Lageen Tubes.
10.12.1 Lageen Tubes. Company Information
10.12.2 Lageen Tubes. Description and Business Overview
10.12.3 Lageen Tubes. Antiviral Drug Packaging Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Lageen Tubes. Antiviral Drug Packaging Products Offered
10.12.5 Lageen Tubes. Recent Development
11 Industry Chain and Sales Channels Analysis
11.1 Antiviral Drug Packaging Industry Chain Analysis
11.2 Antiviral Drug Packaging Key Raw Materials
11.2.1 Key Raw Materials
11.2.2 Raw Materials Key Suppliers
11.3 Antiviral Drug Packaging Production Mode & Process
11.4 Antiviral Drug Packaging Sales and Marketing
11.4.1 Antiviral Drug Packaging Sales Channels
11.4.2 Antiviral Drug Packaging Distributors
11.5 Antiviral Drug Packaging Customers
12 Research Findings and Conclusion
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Figure

List of Tables
Table 1. Antiviral Drug Packaging CAGR in Value, United States VS Global, 2018 VS 2022 VS 2029
Table 2. Antiviral Drug Packaging Market Trends
Table 3. Antiviral Drug Packaging Market Drivers
Table 4. Antiviral Drug Packaging Market Challenges
Table 5. Antiviral Drug Packaging Market Restraints
Table 6. Global Antiviral Drug Packaging Sales Growth Rate (CAGR) by Material: 2018 VS 2022 VS 2029 (US$ Million)
Table 7. United States Antiviral Drug Packaging Sales Growth Rate (CAGR) by Material: 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Antiviral Drug Packaging Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 9. United States Antiviral Drug Packaging Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 10. Global Key Manufacturers of Antiviral Drug Packaging, Ranked by Revenue (2022) & (US$ Million)
Table 11. Global Antiviral Drug Packaging Revenue by Manufacturer, (US$ Million), 2018-2023
Table 12. Global Antiviral Drug Packaging Revenue Share by Manufacturer, 2018-2023
Table 13. Global Antiviral Drug Packaging Sales by Manufacturer, (K Units), 2018-2023
Table 14. Global Antiviral Drug Packaging Sales Share by Manufacturer, 2018-2023
Table 15. Global Antiviral Drug Packaging Price by Manufacturer (2018-2023) & (US$/Unit)
Table 16. Global Antiviral Drug Packaging Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Antiviral Drug Packaging by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiviral Drug Packaging as of 2022)
Table 18. Global Key Manufacturers of Antiviral Drug Packaging, Manufacturing Base Distribution and Headquarters
Table 19. Global Key Manufacturers of Antiviral Drug Packaging, Product Offered and Application
Table 20. Global Key Manufacturers of Antiviral Drug Packaging, Date of Enter into This Industry
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Key Players of Antiviral Drug Packaging in United States, Ranked by Revenue (2022) & (US$ million)
Table 23. United States Antiviral Drug Packaging Revenue by Players, (US$ Million), (2018-2023)
Table 24. United States Antiviral Drug Packaging Revenue Share by Players, (2018-2023)
Table 25. United States Antiviral Drug Packaging Sales by Players, (K Units), (2018-2023)
Table 26. United States Antiviral Drug Packaging Sales Share by Players, (2018-2023)
Table 27. Global Antiviral Drug Packaging Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 28. Global Antiviral Drug Packaging Sales in Volume by Region (2018-2023) & (K Units)
Table 29. Global Antiviral Drug Packaging Sales in Volume Forecast by Region (2024-2029) & (K Units)
Table 30. Global Antiviral Drug Packaging Sales in Value by Region (2018-2023) & (US$ Million)
Table 31. Global Antiviral Drug Packaging Sales in Value Forecast by Region (2024-2029) & (US$ Million)
Table 32. Americas Antiviral Drug Packaging Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. Americas Antiviral Drug Packaging Sales in Value by Country (2018-2023) & (US$ Million)
Table 34. Americas Antiviral Drug Packaging Sales in Value by Country (2024-2029) & (US$ Million)
Table 35. Americas Antiviral Drug Packaging Sales in Volume by Country (2018-2023) & (K Units)
Table 36. Americas Antiviral Drug Packaging Sales in Volume by Country (2024-2029) & (K Units)
Table 37. EMEA Antiviral Drug Packaging Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. EMEA Antiviral Drug Packaging Sales in Value by Country (2018-2023) & (US$ Million)
Table 39. EMEA Antiviral Drug Packaging Sales in Value by Country (2024-2029) & (US$ Million)
Table 40. EMEA Antiviral Drug Packaging Sales in Volume by Country (2018-2023) & (K Units)
Table 41. EMEA Antiviral Drug Packaging Sales in Volume by Country (2024-2029) & (K Units)
Table 42. APAC Antiviral Drug Packaging Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. APAC Antiviral Drug Packaging Sales in Value by Country (2018-2023) & (US$ Million)
Table 44. APAC Antiviral Drug Packaging Sales in Value by Country (2024-2029) & (US$ Million)
Table 45. APAC Antiviral Drug Packaging Sales in Volume by Country (2018-2023) & (K Units)
Table 46. APAC Antiviral Drug Packaging Sales in Volume by Country (2024-2029) & (K Units)
Table 47. Avery Dennison Corporation Company Information
Table 48. Avery Dennison Corporation Description and Business Overview
Table 49. Avery Dennison Corporation Antiviral Drug Packaging Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 50. Avery Dennison Corporation Antiviral Drug Packaging Product
Table 51. Avery Dennison Corporation Recent Development
Table 52. E.I. du Pont de Nemours Company Information
Table 53. E.I. du Pont de Nemours Description and Business Overview
Table 54. E.I. du Pont de Nemours Antiviral Drug Packaging Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 55. E.I. du Pont de Nemours Antiviral Drug Packaging Product
Table 56. E.I. du Pont de Nemours Recent Development
Table 57. CCL Industries Inc Company Information
Table 58. CCL Industries Inc Description and Business Overview
Table 59. CCL Industries Inc Antiviral Drug Packaging Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 60. CCL Industries Inc Antiviral Drug Packaging Product
Table 61. CCL Industries Inc Recent Development
Table 62. BioCote Company Information
Table 63. BioCote Description and Business Overview
Table 64. BioCote Antiviral Drug Packaging Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 65. BioCote Antiviral Drug Packaging Product
Table 66. BioCote Recent Development
Table 67. Avient Company Information
Table 68. Avient Description and Business Overview
Table 69. Avient Antiviral Drug Packaging Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 70. Avient Antiviral Drug Packaging Product
Table 71. Avient Recent Development
Table 72. Mondi Company Information
Table 73. Mondi Description and Business Overview
Table 74. Mondi Antiviral Drug Packaging Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 75. Mondi Antiviral Drug Packaging Product
Table 76. Mondi Recent Development
Table 77. Biomaster Company Information
Table 78. Biomaster Description and Business Overview
Table 79. Biomaster Antiviral Drug Packaging Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 80. Biomaster Antiviral Drug Packaging Product
Table 81. Biomaster Recent Development
Table 82. BASF Company Information
Table 83. BASF Description and Business Overview
Table 84. BASF Antiviral Drug Packaging Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 85. BASF Antiviral Drug Packaging Product
Table 86. BASF Recent Development
Table 87. Lonza Company Information
Table 88. Lonza Description and Business Overview
Table 89. Lonza Antiviral Drug Packaging Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 90. Lonza Antiviral Drug Packaging Product
Table 91. Lonza Recent Development
Table 92. Takex Labo Co. Ltd Company Information
Table 93. Takex Labo Co. Ltd Description and Business Overview
Table 94. Takex Labo Co. Ltd Antiviral Drug Packaging Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 95. Takex Labo Co. Ltd Antiviral Drug Packaging Product
Table 96. Takex Labo Co. Ltd Recent Development
Table 97. Berry Company Information
Table 98. Berry Description and Business Overview
Table 99. Berry Antiviral Drug Packaging Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 100. Berry Antiviral Drug Packaging Product
Table 101. Berry Recent Development
Table 102. Lageen Tubes. Company Information
Table 103. Lageen Tubes. Description and Business Overview
Table 104. Lageen Tubes. Antiviral Drug Packaging Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 105. Lageen Tubes. Antiviral Drug Packaging Product
Table 106. Lageen Tubes. Recent Development
Table 107. Key Raw Materials Lists
Table 108. Raw Materials Key Suppliers Lists
Table 109. Antiviral Drug Packaging Customers List
Table 110. Antiviral Drug Packaging Distributors List
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Antiviral Drug Packaging Product Picture
Figure 2. Global Antiviral Drug Packaging Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 3. Global Antiviral Drug Packaging Market Size 2018-2029 (US$ Million)
Figure 4. Global Antiviral Drug Packaging Sales 2018-2029 (K Units)
Figure 5. United States Antiviral Drug Packaging Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 6. United States Antiviral Drug Packaging Market Size 2018-2029 (US$ Million)
Figure 7. United States Antiviral Drug Packaging Sales 2018-2029 (K Units)
Figure 8. United States Antiviral Drug Packaging Market Share in Global, in Value (US$ Million) 2018-2029
Figure 9. United States Antiviral Drug Packaging Market Share in Global, in Volume (K Units) 2018-2029
Figure 10. Antiviral Drug Packaging Report Years Considered
Figure 11. Product Picture of Rigid Plastic
Figure 12. Product Picture of Flexible Blister Foils
Figure 13. Product Picture of Others
Figure 14. Global Antiviral Drug Packaging Market Share by Material in 2022 & 2029
Figure 15. Global Antiviral Drug Packaging Sales in Value by Material (2018-2029) & (US$ Million)
Figure 16. Global Antiviral Drug Packaging Sales Market Share in Value by Material (2018-2029)
Figure 17. Global Antiviral Drug Packaging Sales by Material (2018-2029) & (K Units)
Figure 18. Global Antiviral Drug Packaging Sales Market Share in Volume by Material (2018-2029)
Figure 19. Global Antiviral Drug Packaging Price by Material (2018-2029) & (US$/Unit)
Figure 20. United States Antiviral Drug Packaging Market Share by Material in 2022 & 2029
Figure 21. United States Antiviral Drug Packaging Sales in Value by Material (2018-2029) & (US$ Million)
Figure 22. United States Antiviral Drug Packaging Sales Market Share in Value by Material (2018-2029)
Figure 23. United States Antiviral Drug Packaging Sales by Material (2018-2029) & (K Units)
Figure 24. United States Antiviral Drug Packaging Sales Market Share in Volume by Material (2018-2029)
Figure 25. United States Antiviral Drug Packaging Price by Material (2018-2029) & (US$/Unit)
Figure 26. Product Picture of Pharmaceuticals
Figure 27. Product Picture of Healthcare
Figure 28. Global Antiviral Drug Packaging Market Share by Application in 2022 & 2029
Figure 29. Global Antiviral Drug Packaging Sales in Value by Application (2018-2029) & (US$ Million)
Figure 30. Global Antiviral Drug Packaging Sales Market Share in Value by Application (2018-2029)
Figure 31. Global Antiviral Drug Packaging Sales by Application (2018-2029) & (K Units)
Figure 32. Global Antiviral Drug Packaging Sales Market Share in Volume by Application (2018-2029)
Figure 33. Global Antiviral Drug Packaging Price by Application (2018-2029) & (US$/Unit)
Figure 34. United States Antiviral Drug Packaging Market Share by Application in 2022 & 2029
Figure 35. United States Antiviral Drug Packaging Sales in Value by Application (2018-2029) & (US$ Million)
Figure 36. United States Antiviral Drug Packaging Sales Market Share in Value by Application (2018-2029)
Figure 37. United States Antiviral Drug Packaging Sales by Application (2018-2029) & (K Units)
Figure 38. United States Antiviral Drug Packaging Sales Market Share in Volume by Application (2018-2029)
Figure 39. United States Antiviral Drug Packaging Price by Application (2018-2029) & (US$/Unit)
Figure 40. Americas Antiviral Drug Packaging Sales in Volume Growth Rate 2018-2029 (K Units)
Figure 41. Americas Antiviral Drug Packaging Sales in Value Growth Rate 2018-2029 (US$ Million)
Figure 42. Americas Antiviral Drug Packaging Sales by Material (2018-2029) & (K Units)
Figure 43. Americas Antiviral Drug Packaging Sales Market Share in Volume by Material (2018-2029)
Figure 44. Americas Antiviral Drug Packaging Sales by Application (2018-2029) & (K Units)
Figure 45. Americas Antiviral Drug Packaging Sales Market Share in Volume by Application (2018-2029)
Figure 46. United States Antiviral Drug Packaging Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 47. Canada Antiviral Drug Packaging Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 48. Mexico Antiviral Drug Packaging Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 49. Brazil Antiviral Drug Packaging Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 50. EMEA Antiviral Drug Packaging Sales in Volume Growth Rate 2018-2029 (K Units)
Figure 51. EMEA Antiviral Drug Packaging Sales in Value Growth Rate 2018-2029 (US$ Million)
Figure 52. EMEA Antiviral Drug Packaging Sales by Material (2018-2029) & (K Units)
Figure 53. EMEA Antiviral Drug Packaging Sales Market Share in Volume by Material (2018-2029)
Figure 54. EMEA Antiviral Drug Packaging Sales by Application (2018-2029) & (K Units)
Figure 55. EMEA Antiviral Drug Packaging Sales Market Share in Volume by Application (2018-2029)
Figure 56. Europe Antiviral Drug Packaging Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 57. Middle East Antiviral Drug Packaging Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 58. Africa Antiviral Drug Packaging Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 59. China Antiviral Drug Packaging Sales in Volume Growth Rate 2018-2029 (K Units)
Figure 60. China Antiviral Drug Packaging Sales in Value Growth Rate 2018-2029 (US$ Million)
Figure 61. China Antiviral Drug Packaging Sales by Material (2018-2029) & (K Units)
Figure 62. China Antiviral Drug Packaging Sales Market Share in Volume by Material (2018-2029)
Figure 63. China Antiviral Drug Packaging Sales by Application (2018-2029) & (K Units)
Figure 64. China Antiviral Drug Packaging Sales Market Share in Volume by Application (2018-2029)
Figure 65. APAC Antiviral Drug Packaging Sales in Volume Growth Rate 2018-2029 (K Units)
Figure 66. APAC Antiviral Drug Packaging Sales in Value Growth Rate 2018-2029 (US$ Million)
Figure 67. APAC Antiviral Drug Packaging Sales by Material (2018-2029) & (K Units)
Figure 68. APAC Antiviral Drug Packaging Sales Market Share in Volume by Material (2018-2029)
Figure 69. APAC Antiviral Drug Packaging Sales by Application (2018-2029) & (K Units)
Figure 70. APAC Antiviral Drug Packaging Sales Market Share in Volume by Application (2018-2029)
Figure 71. Japan Antiviral Drug Packaging Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 72. South Korea Antiviral Drug Packaging Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 73. China Taiwan Antiviral Drug Packaging Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 74. Southeast Asia Antiviral Drug Packaging Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 75. India Antiviral Drug Packaging Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 76. Antiviral Drug Packaging Value Chain
Figure 77. Antiviral Drug Packaging Production Process
Figure 78. Channels of Distribution
Figure 79. Distributors Profiles
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed